JP2023534279A5 - - Google Patents

Info

Publication number
JP2023534279A5
JP2023534279A5 JP2023502926A JP2023502926A JP2023534279A5 JP 2023534279 A5 JP2023534279 A5 JP 2023534279A5 JP 2023502926 A JP2023502926 A JP 2023502926A JP 2023502926 A JP2023502926 A JP 2023502926A JP 2023534279 A5 JP2023534279 A5 JP 2023534279A5
Authority
JP
Japan
Prior art keywords
lipid
compound according
radical
lipophilic
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023502926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023534279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/070020 external-priority patent/WO2022013439A1/en
Publication of JP2023534279A publication Critical patent/JP2023534279A/ja
Publication of JP2023534279A5 publication Critical patent/JP2023534279A5/ja
Pending legal-status Critical Current

Links

JP2023502926A 2020-07-17 2021-07-16 切断可能な脂質化合物、それを含む組成物、およびその使用 Pending JP2023534279A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20305824.3 2020-07-17
EP20305824 2020-07-17
PCT/EP2021/070020 WO2022013439A1 (en) 2020-07-17 2021-07-16 Cleavable lipidic compounds, compositions containing thereof, and uses thereof

Publications (2)

Publication Number Publication Date
JP2023534279A JP2023534279A (ja) 2023-08-08
JP2023534279A5 true JP2023534279A5 (https=) 2024-07-12

Family

ID=72292467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502926A Pending JP2023534279A (ja) 2020-07-17 2021-07-16 切断可能な脂質化合物、それを含む組成物、およびその使用

Country Status (11)

Country Link
US (1) US20230293447A1 (https=)
EP (1) EP4182296A1 (https=)
JP (1) JP2023534279A (https=)
KR (1) KR20230039713A (https=)
CN (1) CN116194084A (https=)
AU (1) AU2021308441A1 (https=)
BR (1) BR112023000568A2 (https=)
CA (1) CA3189373A1 (https=)
IL (1) IL299786A (https=)
MX (1) MX2023000802A (https=)
WO (1) WO2022013439A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025141521A1 (en) 2023-12-29 2025-07-03 Sanofi Lipids having dendritic moieties
WO2026053147A1 (en) 2024-09-05 2026-03-12 Sanofi Pasteur Inc. Helper lipids and lnp compositions comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102354389B1 (ko) 2013-08-21 2022-01-20 큐어백 아게 Rna―암호화된 단백질의 발현을 증가시키는 방법
CN107148410B (zh) * 2014-08-18 2020-04-28 日油株式会社 用于核酸递送的阳离子脂质
US10167253B2 (en) * 2015-06-24 2019-01-01 Nitto Denko Corporation Ionizable compounds and compositions and uses thereof
PL3386484T3 (pl) * 2015-12-10 2022-07-25 Modernatx, Inc. Kompozycje i sposoby dostarczania środków terapeutycznych
CN109475640B (zh) * 2016-06-09 2023-03-10 库瑞瓦格欧洲公司 核酸被运载物的混合载运体
CA3040337A1 (en) * 2016-10-26 2018-05-03 Curevac Ag Lipid nanoparticle mrna vaccines
US10526284B2 (en) * 2016-12-21 2020-01-07 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
US10383952B2 (en) * 2016-12-21 2019-08-20 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
WO2018232120A1 (en) * 2017-06-14 2018-12-20 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
CN114127044A (zh) * 2019-04-25 2022-03-01 英特利亚治疗股份有限公司 可电离的胺类脂质和脂质纳米颗粒

Similar Documents

Publication Publication Date Title
JP2023534279A5 (https=)
JP2022530043A5 (https=)
US7070810B2 (en) Use of buckysome or carbon nanotube for drug delivery
CN103930136B (zh) 含锰纳米结构
EP0584315B1 (fr) Composition cosmetique et/ou pharmaceutique contenant une dispersion de vesicules lipidiques, procede de preparation de ladite dispersion et dispersion de vesicules lipidiques
JP6063627B2 (ja) 診断イメージング用のナノ粒子造影剤
JP2022539089A5 (https=)
JP6762094B2 (ja) 薬剤のデリバリーのためのジスルフィド化合物
CN111249453B (zh) 一种纳米疫苗及其制备方法
EP3298066B1 (en) Dendri-tac and their use as theranostics
JP3631755B2 (ja) ポリオキシエチレン含有脂質二本鎖誘導体
US20110045031A1 (en) Use of Buckysome or Carbon Nanotube for Drug Delivery
JPH05501861A (ja) 界面活性剤の性質を有するフッ素およびリン含有両親媒性分子
JP2024542188A5 (https=)
JP2010505873A5 (ja) 化合物、会合複合体、及び会合複合体を形成する方法
JP2024546951A5 (https=)
WO2007112100A2 (en) Highly fluorinated oils and surfactants and methods of making and using same
FR2665705A1 (fr) Nouveaux derives fluores amphiphiles a structure telomere, leur procede de preparation et leur utilisation dans des preparations a usage biomedical.
FR2988609A1 (fr) Formulation pour l'hormonotherapie
JP2015535811A (ja) MRI用の両親媒性錯体を含む常磁性固体脂質ナノ粒子(pSLN)
WO2006100305A2 (fr) Chelates métalliques de dérivés macrocycliques polyaminocarboxyliques et leur utilisation en imagerie diagnostique
JP2024512770A (ja) 遺伝子送達における非ウイルスベクターとしての樹状構造
EP2030632A1 (en) A carrier particle for use in bio-applications
TW201139421A (en) Novel ep4 agonist
US12396949B2 (en) Technology for improving properties of lipid nanoparticles using lipids in which cis-unsaturated bonds are substituted with a silicon atom